Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
Background: Individual patient meta-analysis to determine the analgesic efficacy and adverse effects of single-dose rofecoxib in primary dysmenorrhoea. Methods: Individual patient information was available from three randomised, double blind, placebo and active controlled trials of rofecoxib. Data w...
| Formatua: | Journal article |
|---|---|
| Argitaratua: |
BioMed Central
2004
|
| Gaiak: |